United States
Germany
Japan
United Kingdom
China
KRAS mouse monoclonal antibody, clone OTI2C1 (formerly 2C1)
| Applications | IHC, WB |
| Reactivities | Human, Mouse, Rat |
Antibodies
KRAS mouse monoclonal antibody, clone OTI4F6 (formerly 4F6)
| Applications | WB |
| Reactivities | Human, Mouse, Rat |
KRAS mouse monoclonal antibody, clone OTI2C1 (formerly 2C1)
| Applications | IHC, WB |
| Reactivities | Human, Mouse, Rat |
Carrier-free (BSA/glycerol-free) KRAS mouse monoclonal antibody, clone OTI1D1 (formerly 1D1)
| Applications | WB |
| Reactivities | Human, Mouse, Rat |
KRAS mouse monoclonal antibody, clone OTI1D1 (formerly 1D1)
| Applications | WB |
| Reactivities | Human, Mouse, Rat |
KRAS mouse monoclonal antibody, clone OTI2G6 (formerly 2G6)
| Applications | WB |
| Reactivities | Human, Mouse, Rat |
KRAS mouse monoclonal antibody, clone OTI6A6 (formerly 6A6)
| Applications | WB |
| Reactivities | Human, Mouse, Rat |
KRAS mouse monoclonal antibody, clone OTI8B4 (formerly 8B4)
| Applications | WB |
| Reactivities | Human, Mouse, Rat |
Carrier-free (BSA/glycerol-free) KRAS mouse monoclonal antibody, clone OTI5H6 (formerly 5H6)
| Applications | WB |
| Reactivities | Human, Mouse, Rat |
活动过滤器
优化搜索结果
Category
Reactivities
Antibody Hosts
Knockout (KO) Validation
Conjugates
Modifications
Isotypes
Clonalities
Assay Types
Brands
Families
Pathways
- Acute myeloid leukemia (57)
- Axon guidance (57)
- B cell receptor signaling pathway (57)
- Bladder cancer (57)
- Chemokine signaling pathway (57)
- Chronic myeloid leukemia (57)
- Colorectal cancer (57)
- Dorso-ventral axis formation (57)
- Endometrial cancer (57)
- ErbB signaling pathway (57)
- Fc epsilon RI signaling pathway (57)
- Gap junction (57)
- Glioma (57)
- GnRH signaling pathway (57)
- Insulin signaling pathway (57)
- Long-term depression (57)
- Long-term potentiation (57)
- MAPK signaling pathway (57)
- Melanogenesis (57)
- Melanoma (57)
- Natural killer cell mediated cytotoxicity (57)
- Neurotrophin signaling pathway (57)
- Non-small cell lung cancer (57)
- Pancreatic cancer (57)
- Pathways in cancer (57)
- Progesterone-mediated oocyte maturation (57)
- Prostate cancer (57)
- Regulation of actin cytoskeleton (57)
- Renal cell carcinoma (57)
- T cell receptor signaling pathway (57)
- Thyroid cancer (57)
- Tight junction (57)
- VEGF signaling pathway (57)
